Hunter C. Smith

2022

In 2022, Hunter C. Smith earned a total compensation of $1.2M as Chief Financial Officer at RHYTHM PHARMACEUTICALS, a 47% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$217,000
Option Awards$412,425
Salary$460,000
Stock Awards$110,500
Other$15,200
Total$1,215,125

Smith received $460K in salary, accounting for 38% of the total pay in 2022.

Smith also received $217K in non-equity incentive plan, $412.4K in option awards, $110.5K in stock awards and $15.2K in other compensation.

Rankings

In 2022, Hunter C. Smith's compensation ranked 2,652nd out of 5,756 executives tracked by ExecPay. In other words, Smith earned more than 53.9% of executives.

ClassificationRankingPercentile
All
2,652
out of 5,756
54th
Division
Manufacturing
1,472
out of 3,133
53rd
Major group
Chemicals And Allied Products
674
out of 1,419
53rd
Industry group
Drugs
627
out of 1,320
53rd
Industry
Pharmaceutical Preparations
452
out of 966
53rd

Pay ratio

Hunter C. Smith's Pay$1,215,125
Median Employee's Pay$286,392
Pay Ratio

4

to 1

In 2022, the annual total compensation of Hunter C. Smith was $1,215,125.

The annual total compensation of the median employee at RHYTHM PHARMACEUTICALS was $286,392.

The ratio of Hunter C. Smith's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 27, 2023.

Smith's colleagues

We found four more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2022.

2022

David Meeker

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2022

Yann Mazabraud

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of International

2022

Jennifer Chien

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of North America

2022

Joseph Shulman

RHYTHM PHARMACEUTICALS

Chief Technical Officer

News

You may also like